These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 10935851)

  • 1. Psychotic disorder after lamotrigine.
    Polselli GM; Pennisi EM; Figà Talamanca L; Roberti R; Garelli FF; Bandinelli PL
    Ital J Neurol Sci; 1998 Apr; 19(2):124-5. PubMed ID: 10935851
    [No Abstract]   [Full Text] [Related]  

  • 2. Disabling tremor after lamotrigine with sodium valproate.
    Reutens DC; Duncan JS; Patsalos PN
    Lancet; 1993 Jul; 342(8864):185-6. PubMed ID: 8101290
    [No Abstract]   [Full Text] [Related]  

  • 3. Loss of aura in lamotrigine-treated epilepsy.
    Deleu D; Hanssens Y
    Lancet; 1997 Dec; 350(9093):1751-2. PubMed ID: 9413474
    [No Abstract]   [Full Text] [Related]  

  • 4. Facial tic associated with lamotrigine in adults.
    Musiek ES; Anderson CT; Dahodwala NA; Pollard JR
    Mov Disord; 2010 Jul; 25(10):1512-3. PubMed ID: 20629145
    [No Abstract]   [Full Text] [Related]  

  • 5. Lamotrigine versus carbamazepine in epilepsy.
    Duval X; Chosidow O; Semah F; Lipsker D; Francès C; Herson S
    Lancet; 1995 May; 345(8960):1301-2. PubMed ID: 7746067
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hallucinosis using lamotrigine].
    Huber B; Hilgemann C
    Nervenarzt; 2009 Feb; 80(2):202-3. PubMed ID: 19189076
    [No Abstract]   [Full Text] [Related]  

  • 7. Disabling erratic myoclonus during lamotrigine therapy with high serum level--report of two cases.
    Janszky J; Rásonyi G; Halász P; Olajos S; Perényi J; Szûcs A; Debreczeni T
    Clin Neuropharmacol; 2000; 23(2):86-9. PubMed ID: 10803798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrent severe aseptic meningitis after exposure to lamotrigine in a patient with systemic lupus erythematosus.
    Kilfoyle DH; Anderson NE; Wallis WE; Nicholls DW
    Epilepsia; 2005 Feb; 46(2):327-8. PubMed ID: 15679516
    [No Abstract]   [Full Text] [Related]  

  • 9. Neurotoxicity following addition of intravenous valproate to lamotrigine therapy.
    Burneo JG; Limdi N; Kuzniecky RI; Knowlton RC; Mendez M; Lawn N; Faught E; Welty TE; Prasad A
    Neurology; 2003 Jun; 60(12):1991-2. PubMed ID: 12821749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective, open-label, add-on study of lamotrigine in 56 children with intractable generalized epilepsy.
    Farrell K; Connolly MB; Munn R; Peng S; MacWilliam LM
    Pediatr Neurol; 1997 Apr; 16(3):201-5. PubMed ID: 9165509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of psychosis in patients with epilepsy treated with lamotrigine: report of six cases and review of the literature.
    Brandt C; Fueratsch N; Boehme V; Kramme C; Pieridou M; Villagran A; Woermann F; Pohlmann-Eden B
    Epilepsy Behav; 2007 Aug; 11(1):133-9. PubMed ID: 17485241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Lamotrigine (Lamictal)].
    Scheen AJ
    Rev Med Liege; 1997 Nov; 52(11):738-40. PubMed ID: 9480501
    [No Abstract]   [Full Text] [Related]  

  • 13. Oral hairy leukoplakia in a patient on long-term anticonvulsant treatment with lamotrigine.
    Gordins P; Sloan P; Spickett GP; Staines KS
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 May; 111(5):e17-23. PubMed ID: 21429773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lamotrigine in primary generalised epilepsy.
    Timmings PL; Richens A
    Lancet; 1992 May; 339(8804):1300-1. PubMed ID: 1349698
    [No Abstract]   [Full Text] [Related]  

  • 15. [Optimizing epilepsy therapy in children and adolescents with lamotrigine].
    Siemes H; Brandl U; Helmstädter C; Kurlemann G; Rating D; Sälke-Kellermann RA; Stephani U; Uberall M; Wiemer-Kruel A; Bergmann L
    Klin Padiatr; 2005; 217(4):222-9. PubMed ID: 16032548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pharmacoepidemiologic study of factors influencing the outcome of treatment with lamotrigine in chronic epilepsy.
    Wong IC; Mawer GE; Sander JW; Lhatoo SD
    Epilepsia; 2001 Oct; 42(10):1354-8. PubMed ID: 11737172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anticonvulsant hypersensitivity syndrome and lamotrigine-associated anticonvulsant hypersensitivity syndrome].
    Taillia H; Alla P; Fournier B; Bounolleau P; Ouologem M; Ricard D; Sallansonnet-Froment M; de Greslan T; Renard JL
    Rev Neurol (Paris); 2009 Oct; 165(10):821-7. PubMed ID: 19362726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lamotrigine for generalised epilepsies.
    Stewart J; Hughes E; Reynolds EH
    Lancet; 1992 Nov; 340(8829):1223. PubMed ID: 1359288
    [No Abstract]   [Full Text] [Related]  

  • 19. Lamotrigine-induced rash--worth a rechallenge.
    P-Codrea Tigaran S; Sidenius P; Dam M
    Acta Neurol Scand; 2005 Mar; 111(3):191-4. PubMed ID: 15736314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lamotrigine and seizure aggravation in severe myoclonic epilepsy.
    Guerrini R; Dravet C; Genton P; Belmonte A; Kaminska A; Dulac O
    Epilepsia; 1998 May; 39(5):508-12. PubMed ID: 9596203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.